PC
Polar Capital Portfolio holdings
AUM
$13.5B
This Quarter Return
+0.63%
1 Year Return
+55.85%
3 Year Return
+125.38%
5 Year Return
+259.12%
10 Year Return
–
AUM
$10.9B
AUM Growth
+$10.9B
(-4.4%)
Cap. Flow
-$364M
Cap. Flow
% of AUM
-3.34%
Top 10 Holdings %
Top 10 Hldgs %
25.24%
Holding
324
New
42
Increased
91
Reduced
108
Closed
45
Top Buys
| 1 |
Apple
AAPL
|
$62.5M |
| 2 |
Intuitive Surgical
ISRG
|
$59.2M |
| 3 |
Edwards Lifesciences
EW
|
$57.8M |
| 4 |
AbbVie
ABBV
|
$56.2M |
| 5 |
Agilent Technologies
A
|
$54.9M |
Top Sells
| 1 |
Arista Networks
ANET
|
$58.9M |
| 2 |
MDSO
Medidata Solutions, Inc.
MDSO
|
$55.9M |
| 3 |
Pfizer
PFE
|
$51.6M |
| 4 |
Visa
V
|
$49.4M |
| 5 |
Autodesk
ADSK
|
$46.1M |
Sector Composition
| 1 | Technology | 28.86% |
| 2 | Financials | 24.44% |
| 3 | Healthcare | 16.93% |
| 4 | Communication Services | 9.5% |
| 5 | Consumer Discretionary | 6.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
KalVista Pharmaceuticals
KALV
$709M
| $16.3M | 0.15% |
1,403,735
+16,235
| +1% | +$188K |
|
152
Eli Lilly
LLY
$656B
| $16.3M | 0.15% |
+145,416
| New | +$16.3M |
|
153
Insulet
PODD
$24.2B
| $15.4M | 0.14% |
+93,610
| New | +$15.4M |
|
154
Toronto Dominion Bank
TD
$127B
| $15.4M | 0.14% |
223,494
+2,943
| +1% | +$203K |
|
|
RARX
155
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $15.3M | 0.14% |
+645,412
| New | +$15.3M |
|
156
Heritage Insurance Holdings
HRTG
$713M
| $14.8M | 0.13% |
990,000
| – | – |
|
157
Cigna
CI
$80.5B
| $14.8M | 0.13% |
+97,500
| New | +$14.8M |
|
158
Grifois
GRFS
$6.59B
| $14.6M | 0.13% |
731,000
-62,000
| -8% | -$1.24M |
|
159
PNC Financial Services
PNC
$80.2B
| $14M | 0.13% |
99,998
+3,137
| +3% | +$440K |
|
|
BLU
160
DELISTED
BELLUS Health Inc.
BLU
| $14M | 0.13% |
+2,113,673
| New | +$14M |
|
161
CONMED
CNMD
$1.66B
| $13.9M | 0.13% |
+144,634
| New | +$13.9M |
|
|
CTLT
162
DELISTED
CATALENT, INC.
CTLT
| $13.6M | 0.12% |
285,115
+71,263
| +33% | +$3.4M |
|
163
Wayfair
W
$10B
| $13.5M | 0.12% |
120,663
-61,926
| -34% | -$6.94M |
|
164
Copa Holdings
CPA
$4.74B
| $13.5M | 0.12% |
136,491
-325,643
| -70% | -$32.2M |
|
165
HCA Healthcare
HCA
$94.9B
| $13.4M | 0.12% |
+111,323
| New | +$13.4M |
|
|
DERM
166
DELISTED
Dermira, Inc.
DERM
| $13.1M | 0.12% |
2,043,680
-894,017
| -30% | -$5.71M |
|
|
SIEN
167
DELISTED
Sientra, Inc.
SIEN
| $13M | 0.12% |
2,000,000
| – | – |
|
|
PTLA
168
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $12.6M | 0.11% |
+471,362
| New | +$12.6M |
|
169
Ares Capital
ARCC
$15.7B
| $12.5M | 0.11% |
671,000
-14,000
| -2% | -$261K |
|
|
PRAH
170
DELISTED
PRA Health Sciences, Inc.
PRAH
| $12.3M | 0.11% |
+124,400
| New | +$12.3M |
|
171
Becton Dickinson
BDX
$54.2B
| $12.3M | 0.11% |
48,557
-19,143
| -28% | -$4.84M |
|
|
AMRN
172
Amarin Corp
AMRN
$319M
| $11.4M | 0.1% |
750,000
+250,000
| +50% | +$3.79M |
|
|
MRTX
173
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $11.3M | 0.1% |
145,148
+120,148
| +481% | +$9.36M |
|
174
Citizens Financial Group
CFG
$22.1B
| $10.6M | 0.1% |
299,608
+49,216
| +20% | +$1.74M |
|
|
DCPH
175
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $10.4M | 0.09% |
+305,978
| New | +$10.4M |
|